Human pluripotent stem cells (hPSCs) are increasingly used for cell-based regenerative therapies worldwide, with embryonic and induced pluripotent stem cells as potential treatments for debilitating and chronic conditions, such as age-related macular degeneration, Parkinson's disease, spinal cord injuries, and type 1 diabetes. However, with the level of genomic anomalies stem cells generate in culture, their safety may be in question. Specifically, hPSCs frequently acquire chromosomal abnormalities, often with gains or losses of whole chromosomes. This review discusses how important it is to efficiently and sensitively detect hPSC aneuploidies, to understand how these aneuploidies arise, consider the consequences for the cell, and indeed the individual to whom aneuploid cells may be administered.
CITATION STYLE
Henry, M. P., Hawkins, J. R., Boyle, J., & Bridger, J. M. (2019). The genomic health of human pluripotent stem cells: Genomic instability and the consequences on nuclear organization. Frontiers in Genetics, 10(JAN). https://doi.org/10.3389/fgene.2018.00623
Mendeley helps you to discover research relevant for your work.